HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Ebihara Selected Research

candesartan cilexetil (Amias)

9/2002Combination therapy of trandolapril and candesartan cilexetil reduces microalbuminuria and urinary endothelin-1 excretion in patients with type 2 diabetes.
11/2000Effects of the angiotensin II receptor antagonist candesartan cilexetil on blood pressure and proteinuria in patients with autosomal dominant polycystic kidney disease.
10/2000Comparison between the angiotensin II receptor antagonist candesartan cilexetil and the angiotensin-converting enzyme inhibitor trandolapril in microalbuminuria of patients with early diabetic nephropathy.
9/2000Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Ebihara Research Topics

Disease

5Diabetic Nephropathies (Diabetic Nephropathy)
09/2002 - 06/2000
5IGA Glomerulonephritis (IGA Nephropathy)
09/2001 - 07/2000
5Sepsis (Septicemia)
11/2000 - 01/2000
4Proteinuria
02/2002 - 06/2000
3Type 2 Diabetes Mellitus (MODY)
09/2002 - 09/2000
3Lupus Nephritis
02/2002 - 08/2000
2Autoimmune Diseases (Autoimmune Disease)
02/2002 - 01/2000
2Autosomal Dominant Polycystic Kidney (ADPKD)
05/2001 - 11/2000
1Vasculitis (Vasculitides)
10/2016
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
10/2016
1Infections
10/2016
1Hypertension (High Blood Pressure)
07/2003
1Respiratory Insufficiency (Respiratory Failure)
11/2001
1Poisoning
11/2001
1Dyslipidemias (Dyslipidemia)
11/2001
1Acute Kidney Injury (Acute Renal Failure)
10/2000
1Interstitial Lung Diseases (Interstitial Lung Disease)
10/2000
1Rhabdomyolysis
10/2000
1Glomerulonephritis
09/2000
1Chronic Kidney Failure (Chronic Renal Failure)
05/2000
1Septic Shock (Toxic Shock Syndrome)
03/2000
1Inflammation (Inflammations)
01/2000
1Silicosis
01/2000
1Brain Diseases (Brain Disorder)
01/2000
1Pneumoconiosis
01/2000
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
01/2000
1Massive Hepatic Necrosis
01/2000
1Cystic Kidney Diseases (Cystic Kidney Disease)
01/2000
1Neoplasms (Cancer)
01/2000
1Hepatitis
01/2000

Drug/Important Bio-Agent (IBA)

5Polymyxin B (Aerosporin)FDA LinkGeneric
11/2000 - 01/2000
4Endothelins (Endothelin)IBA
07/2003 - 03/2000
4candesartan cilexetil (Amias)FDA Link
09/2002 - 09/2000
3AlbuminsIBA
09/2002 - 09/2000
3trandolapril (Mavik)FDA LinkGeneric
09/2002 - 09/2000
3Tissue Inhibitor of Metalloproteinase-1IBA
11/2001 - 01/2000
3DilazepIBA
05/2001 - 07/2000
3Angiotensin Receptor AntagonistsIBA
11/2000 - 09/2000
2Endothelin-1 (Endothelin 1)IBA
09/2002 - 03/2000
2SteroidsIBA
02/2002 - 08/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2002 - 02/2001
2Collagen Type IV (Type IV Collagen)IBA
11/2001 - 01/2000
2Pioglitazone (Actos)FDA Link
11/2001 - 09/2000
2Immunoglobulin A (IgA)IBA
09/2001 - 09/2000
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
05/2001 - 08/2000
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2000 - 09/2000
2CreatinineIBA
09/2000 - 09/2000
1Scavenger Receptors (Scavenger Receptor)IBA
10/2016
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2016
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2003
1ErythropoietinFDA Link
07/2003
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
09/2002
1AngiotensinsIBA
09/2002
1AutoantibodiesIBA
02/2002
1Antigen-Antibody Complex (Immune Complex)IBA
02/2002
1ParaquatIBA
11/2001
1Immunoglobulin E (IgE)IBA
02/2001
1mizoribineIBA
02/2001
1Azathioprine (Imuran)FDA LinkGeneric
02/2001
1Phosphates (Orthophosphate)IBA
11/2000
1voglibose (Basen)IBA
09/2000
1Antihypertensive Agents (Antihypertensives)IBA
09/2000
11,4-dihydropyridine (dihydropyridine)IBA
09/2000
1Insulin (Novolin)FDA Link
09/2000
1CalciumIBA
09/2000
1Glyburide (Glibenclamide)FDA LinkGeneric
09/2000
1Verapamil (Calan)FDA LinkGeneric
09/2000
1P-SelectinIBA
07/2000
1AcarboseFDA LinkGeneric
06/2000
1Blood Glucose (Blood Sugar)IBA
06/2000
1antineoplaston A10 (A 10)IBA
03/2000
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2000
1Matrix Metalloproteinases (MMPs)IBA
01/2000
1Metalloproteases (Metalloproteinases)IBA
01/2000
1MineralsIBA
01/2000
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2000
1Interleukin-6 (Interleukin 6)IBA
01/2000
1CytokinesIBA
01/2000
1Transforming Growth Factor beta (TGF-beta)IBA
01/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2000

Therapy/Procedure

6Renal Dialysis (Hemodialysis)
07/2003 - 01/2000
5Therapeutics
09/2002 - 01/2000
2Hemoperfusion
10/2000 - 08/2000
1Plasmapheresis
02/2002
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
05/2000
1Plasma Exchange
01/2000